Trademark: 90579209
Word
MEDAC
Status Date
Thursday, June 6, 2024
Filing Date
Monday, March 15, 2021
Published for Opposition
Tuesday, December 14, 2021
5 Pharmaceutical preparations for treating and diagnosing cancer, autoimmune diseases, urologic diseases; pharmaceutical preparations for use in fibrinolysis, hematology and dermatology
Mar 18, 2021
New Application Entered
Jun 14, 2021
New Application Office Supplied Data Entered
Aug 14, 2021
Assigned To Examiner
Aug 20, 2021
Non-Final Action Written
Aug 20, 2021
Non-Final Action E-Mailed
Aug 20, 2021
Notification Of Non-Final Action E-Mailed
Nov 5, 2021
Teas Response To Office Action Received
Nov 5, 2021
Correspondence Received In Law Office
Nov 5, 2021
Teas/Email Correspondence Entered
Nov 5, 2021
Approved For Pub - Principal Register
Nov 24, 2021
Notification Of Notice Of Publication E-Mailed
Dec 14, 2021
Published For Opposition
Dec 14, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 8, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 7, 2022
Sou Teas Extension Received
Jul 7, 2022
Sou Extension 1 Filed
Jul 7, 2022
Sou Extension 1 Granted
Jul 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 21, 2022
Sou Teas Extension Received
Dec 21, 2022
Sou Extension 2 Filed
Dec 21, 2022
Sou Extension 2 Granted
Dec 23, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 30, 2023
Sou Teas Extension Received
Jun 30, 2023
Sou Extension 3 Filed
Jun 30, 2023
Sou Extension 3 Granted
Jul 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 12, 2024
Sou Teas Extension Received
Jan 12, 2024
Sou Extension 4 Filed
Jan 12, 2024
Sou Extension 4 Granted
Jan 16, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 6, 2024
Sou Teas Extension Received
Jun 6, 2024
Sou Extension 5 Filed
Jun 6, 2024
Sou Extension 5 Granted
Jun 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
